Biote Corp. BTMD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70.1%-1.3pp | 71.5%-0.9pp | 72.4%+0.4pp | 72%+0.7pp | 71.3%+0.7pp | |
| Operating margin | 15.4%-3.1pp | 18.5%+2.4pp | 16.1%-1.7pp | 17.8%+2.3pp | 15.5%-0.5pp | |
| Net margin | 8.3%-5.8pp | 14.1%-0.6pp | 14.7%-1.0pp | 15.7%+5.2pp | 10.6%+8.9pp | |
| Efficiency | ||||||
| Asset turnover | 1.8×+0.1× | 1.7×-0.2× | 1.8×-0.2× | 2×+0.6× | 1.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.3×+0.1× | 1.2×+0.2× | 1×0.0× | 1×-0.4× | 1.4×+0.1× | |
| Leverage | ||||||
| Net debt / EBITDA | 3×+0.9× | 2.1×-0.2× | 2.2×0.0× | 2.3×+0.3× | 2×-0.1× | |
| Per Share | ||||||
| Book value per share | -$1.56+2.4% | -$1.60+19.4% | -$1.98+26.1% | -$2.68-10.1% | -$2.44+21.2% | |
| Valuation | ||||||
| Market capitalization | $57.33M-51.2% | $79.77M-16.1% | $95.08M-24.3% | $125.63M+19.8% | $104.85M-45.5% | |
| Price / earnings | 3.7×-0.1× | 2.9×-0.4× | 3.3×-0.7× | 4×-1.0× | 5×-55.9× | |
| Price / sales | 0.3×-0.3× | 0.4×-0.1× | 0.5×-0.1× | 0.6×+0.1× | 0.5×-0.4× | |
| EV / EBITDA | 5×-0.7× | 4.1×-0.8× | 4.9×-0.6× | 5.5×+0.5× | 5×-2.5× | |
| Dividend yield | 2.2%+0.6pp | 2.2%+0.4pp | 1.8%+0.1pp | 1.7%-3.4pp | 5.1%+2.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Biote Corp.'s profit margins?
- Biote Corp. (BTMD) runs a 70.1% gross margin and a 15.4% operating margin, with a 8.3% net margin.
- Where do Biote Corp.'s ratios come from?
- Every ratio is computed from Biote Corp.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
